Yahoo Canada Web Search

Search results

1. www.foxchase.org › news › 2024/07/22-dr-sanjay-reddyDr. Sanjay S. Reddy Promoted to Division Chief of Surgical ...

   www.foxchase.org › news › 2024/07/22-dr-sanjay-reddy

   • Cached

   5 days ago · PHILADELPHIA (July 22, 2024) — Sanjay S. Reddy, MD, FACS, an Associate Professor in the Department of Surgery, Program Director of the Complex General Surgical Oncology Fellowship, and Co-Director of the Marvin & Concetta Greenberg Pancreatic Cancer Institute, has been promoted to Division Chief of Surgical Oncology at Fox Chase Cancer Center.

2. www.cnbctv18.com › market › dr-reddys-laboratoriesStock Split — Dr. Reddy's to consider sub-division of its ...

   www.cnbctv18.com › market › dr-reddys-laboratories

   • Cached

   2 days ago · This acquisition includes the purchase of shares of Northstar Switzerland SARL, a Haleon group company. Dr. Reddy’s will acquire the share capital of Northstar Switzerland SARL for a total consideration of GBP 500 million with an upfront cash payment of GBP 458 million and performance-based contingent payments of up to GBP 42 million, payable in 2025 and 2026.

3. www.gilmermirror.com › 2024/07/22 › ut-health-eastUT Health East Texas Physicians Welcomes Shivanandan Reddy ...

   www.gilmermirror.com › 2024/07/22 › ut-health-east

   • Cached

   5 days ago · Shivanandan Reddy, MD Tyler, Texas (July 22, 2024) ─ UT Health East Texas is expanding pediatric services in Tyler with the addition of board-certified pediatrician Shivanandan Reddy, MD. “My care philosophy emphasizes building strong relationships, providing education and ensuring the right plan of care for each patient.

4. www.ndtvprofit.com › business › nestle-india-and-drNestle India And Dr. Reddy's Laboratories Form New Joint ...

   www.ndtvprofit.com › business › nestle-india-and-dr

   • Cached

   3 days ago · Nestle India Ltd., and Dr Reddy's Laboratories Ltd. announced the formation of joint venture named "Dr. Reddy’s and Nestlé Health Science Limited”. Nestle will hold 49% of the equity shares and Dr. Reddy's Laboratories holds 51% of the 100,000 equity shares that have a face value of Rs.10.

5. www.moneycontrol.com › news › businessDr Reddy's Labs Q1 Preview: Tepid US sales likely to put ...

   www.moneycontrol.com › news › business

   • Cached

   1 day ago · According to a Moneycontrol poll of eleven brokerages, Dr Reddy's Laboratories' revenue is estimated to grow 7.5 percent to Rs 7,242 crore in Q1 of FY25, compared to Rs 6,738 crore recorded in the ...

6. seekingalpha.com › symbol › RDYDr. Reddy's Laboratories Limited (RDY) Latest Stock Analysis

   seekingalpha.com › symbol › RDY

   • Cached

   5 days ago · Dr. Reddy's: Continued Q2 Earnings Growth, Supports Long-Term Investment Outlook Zach Bristow Fri, Oct. 27, 2023 Dr. Reddy's: Growth Supported By New Labels, Profitability

7. People also ask

   Who is Nandan Reddy?

   • Nandan Reddy is a BITS Pilani alumnus and has previously worked as a consultant and has built another start-up around a tablet-based POS for restaurants. He has been a part of the core management team at Source Pilani, India’s first rural BPO.

   Nandan Reddy, Co-founder, Swiggy - IndiaRetailing.com

   indiaretailing.com/2020/01/09/nandan-reddy-co-founder-swiggy/

   See all results for this question

   Is Dr Reddy's a public company?

   • Currently, shares of Dr. Reddy's have a face value of ₹5 each. This is the first instance that the company will be carrying out a split of its equity share as a public company. It added that these will also include the American depository shares (ADRs). The same will be subject to approval of the company's shareholders.

   Stock Split — Dr. Reddy's to consider sub-division of its shares on July 27

   www.cnbctv18.com/market/dr-reddys-laboratories-share-price-stock-split-board-meet-july-27-record-date-2024-returns-q1-results-19448106.htm

   See all results for this question

   Did Dr Reddy's miss earnings estimates?

   • The company's March quarter earnings missed estimates. The drugmaker reported EBITDA margin of 26.4% for the quarter, which was lower than the CNBC-TV18 poll estimate of 28%. In an interaction with CNBC-TV18, Dr. Reddy's MD & CEO Erez Israeli said that the margins for the quarter were impacted due to higher expenses.

   Stock Split — Dr. Reddy's to consider sub-division of its shares on July 27

   www.cnbctv18.com/market/dr-reddys-laboratories-share-price-stock-split-board-meet-july-27-record-date-2024-returns-q1-results-19448106.htm

   See all results for this question

8. pharmagroww.com › job › regulatory-affairs-traineeRegulatory Affairs Trainee Freshers Job opening at Dr. Reddy ...

   pharmagroww.com › job › regulatory-affairs-trainee

   5 days ago · About Company. We are seeking a Regulatory Affairs Trainee for our RA department. This role is ideal for fresh graduates (preferably females) Position Name : Regulatory Affairs Trainee. Organization : Dr. Reddy’s Laboratories. Qualification: B.Pharm, M.Pharm, Pharm.D, Msc, BSc. Experience: 0 YEARS / Freshers.